 |
Quotes delayed 20 minutes
|
|
|
 Preferred Stock Offerings
By Preferred Stock Channel Staff, updated Monday, January 25, 5:10 PM
Slide #184. Rennova Health, Inc. — Preferred Stock Offering
| Company: |
Rennova Health, Inc. (RNVA) |
| Date announced: |
12/16/2016 |
| Shares Offered: |
12,350 |
| Date of Pricing: |
12/16/2016 |
| Price Per Share: |
$1,000 |
| Preferred Stock Offering Details: |
Rennova Health, Inc. (NASDAQ: RNVA) today announced the pricing of an underwritten public offering of 12,350 shares of its Series H Convertible Preferred Stock at a per share price to the public of $1,000. The Series H Preferred Stock has a stated value of $1,000 per share with each share convertible into 11,111 shares of common stock, at a conversion price of $0.09 per share. The gross proceeds to Rennova Health, Inc. from this offering are expected to be approximately $12,350,000 before deducting underwriting discounts and commissions and other estimated offering expenses. Approximately $8,300,000 of the net proceeds from this offering will be used to redeem certain outstanding shares of Rennova Health's Series G Convertible Preferred Stock. The offering is expected to close on December 20, 2016, subject to customary closing conditions. |
Rennova Health is a provider of a group of health care services for healthcare providers, their patients and individuals. Co. operates in three synergistic divisions with specialized management: Clinical diagnostics through its clinical laboratories, with emphasis on the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities; supportive software solutions to healthcare providers including Electronic Health Records, Laboratory Information Systems and Medical Billing services; Decision support and interpretation of cancer and genomic diagnostics.
 Open the RNVA Page at Preferred Stock Channel »
Open the RNVA Page at Preferred Stock Channel (in a new window) »
|
|
